![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Polzin, Amin; Dannenberg, Lisa; M'Pembele, Rene; Mourikis, Philipp; Naguib, David; Zako, Saif; Helten, Carolin; Petzold, Tobias; Levkau, Bodo; Hohlfeld, Thomas; Barth, Mareike; Zeus, Tobias; Sixt, Stephan; Huhn, Ragnar; Akhyari, Payam; Lichtenberg, Artur; Kelm, Malte und Hoffmann, Till
(2022):
Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis.
In: Scientific Reports, Bd. 12, Nr. 1, 12933
M'Pembele, Rene; Ahlbrecht, Samantha; Helten, Carolin; Mourikis, Philipp; Naguib, David; Zako, Saif; Trojovsky, Kajetan; Huhn, Ragnar; Petzold, Tobias; Hohlfeld, Thomas; Zeus, Tobias; Kelm, Malte; Dannenberg, Lisa und Polzin, Amin
(2022):
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel.
In: Pharmacology, Bd. 108, Nr. 1: S. 83-89
Mourikis, Philipp; Zako, Saif; Dannenberg, Lisa; Helten, Carolin; Naguib, David; Hohlfeld, Thomas; Petzold, Tobias; Levkau, Bodo; Zeus, Tobias; Kelm, Malte und Polzin, Amin
(2020):
Aspirin antiplatelet effects are associated with body weight.
In: Vascular Pharmacology, Bd. 125, 106635
Dannenberg, Lisa; Metzen, Daniel; Zako, Saif; Poehl, Martin; Mourikis, Philipp; Helten, Carolin; Trojovsky, Kajetan; Naguib, David; Konsek, Daniel; Knoop, Betuel; Ayhan, Aysel; Hohlfeld, Thomas; Petzold, Tobias; Levkau, Bodo; Veulemans, Verena; Zeus, Tobias; Kelm, Malte und Polzin, Amin
(2020):
Enhanced Platelet Reactivity under Aspirin Medication and Major Adverse Cardiac and Cerebrovascular Events in Patients with Coronary Artery Disease.
In: Pharmacology, Bd. 105: S. 118-122
Dannenberg, Lisa; Petzold, Tobias; Achilles, Alina; Naguib, David; Zako, Saif; Helten, Carolin; M'Pembele, Rene; Mourikis, Philipp; Podsvyadek, Yanina; Grandoch, Maria; Levkau, Bodo; Zeus, Tobias; Kelm, Malte; Hohlfeld, Thomas und Polzin, Amin
(2019):
Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients.
In: European Journal of Clinical Pharmacology, Bd. 75, Nr. 1: S. 13-20